GNOM - Health Care Sector Innovation And Insight
By Stephen H. Dover, CFA, Executive Vice President, Head of Equities, Krzysztof Musialik, CFA, Research Analyst, Franklin Templeton Emerging Markets Equity, and Steve Kornfeld, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group
The biopharma industry has the potential to save lives with dramatic breakthroughs in new therapeutic drugs. In our latest "Talking Markets" podcast, our Head of Equities, Stephen Dover, speaks with analysts Steven Kornfeld and Krzysztof Musialik about health care innovations, particularly in the area of biopharma. They point out that in some cases, emerging markets are actually leading the way.
A transcript of